FSD Pharma Inc (HUGE)
0.28
-0.02
(-6.67%)
USD |
NASDAQ |
Jun 03, 10:16
FSD Pharma Total Assets (Quarterly): 15.44M for March 31, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 15.44M |
December 31, 2023 | 17.47M |
September 30, 2023 | 18.94M |
June 30, 2023 | 21.41M |
March 31, 2023 | 29.48M |
December 31, 2022 | 38.41M |
September 30, 2022 | 43.58M |
June 30, 2022 | 51.17M |
March 31, 2022 | 55.71M |
December 31, 2021 | 62.96M |
September 30, 2021 | 68.67M |
June 30, 2021 | 68.35M |
March 31, 2021 | 76.44M |
December 31, 2020 | 41.97M |
September 30, 2020 | 41.99M |
Date | Value |
---|---|
June 30, 2020 | 38.09M |
March 31, 2020 | 35.06M |
December 31, 2019 | 43.22M |
September 30, 2019 | 52.98M |
June 30, 2019 | 54.46M |
March 31, 2019 | 38.20M |
December 31, 2018 | 38.75M |
September 30, 2018 | 51.53M |
June 30, 2018 | 40.15M |
March 31, 2018 | 11.87M |
February 28, 2018 | 1.754M |
November 30, 2017 | 0.0101M |
August 31, 2017 | 0.014M |
May 31, 2017 | 0.0153M |
August 31, 2016 | 0.0071M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
15.44M
Minimum
Mar 2024
76.44M
Maximum
Mar 2021
43.79M
Average
42.60M
Median
Total Assets (Quarterly) Benchmarks
Acasti Pharma Inc | 76.18M |
Aurinia Pharmaceuticals Inc | 548.06M |
Edesa Biotech Inc | 6.475M |
Lexaria Bioscience Corp | 6.352M |
Xenon Pharmaceuticals Inc | 919.02M |
Total Assets (Quarterly) Related Metrics
Total Liabilities (Quarterly) | 3.924M |
Shareholders Equity (Quarterly) | 12.03M |